Hutchmed China (HCM.US) Stock Community - Hot Topic Discussions - Longbridge

Quote List Quote List

Event Tracking

Dec8

HUTCHMED Pharmaceuticals' Medicines Renewed for National Health Insurance and Innovative Commercial Health Insurance Drug Catalog

00:16

Nov28

Hutchmed China Ltd Announces Issued Share Capital as of November 28, 2025

08:31

Nov27

Hutchison China MediTech to Present New Clinical Data on Cancer Therapies at ESMO Asia and ASH Meetings

00:00

Nov11

Hopson Pharmaceutical Shares Latest R&D Progress, Pushing ATTC Platform and Candidates

02:42

Nov10

Eastern Securities Gives Huang Medicine Buy Rating and Revenue Projections for 2025-2027

06:41

Nov7

CICC Maintains Outperform Industry Rating on HutchMed, Recommends Attention to ATTC Platform Technology Validation and Savolitinib Clinical Trial Progress

01:39

Schedules & Filings

Schedules

Filings

Aug7

Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 138.84 M, Net Income 227.48 M, EPS 1.3

Mar19

Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 162.26 M, Net Income 5.964 M, EPS 0.025

Jul31

Earning Release(EST)

FY2024 Q2 Earning Release (USD) Revenue 152.84 M, Net Income 12.9 M, EPS 0.075

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More